相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents
Kaixiang Zhou et al.
MOLECULAR PHARMACEUTICS (2021)
Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease
Steven Y. Yap et al.
BRAIN (2021)
Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles
Michel Koole et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study
Ying Wang et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Tau deposition is associated with functional isolation of the hippocampus in aging
Theresa M. Harrison et al.
NATURE COMMUNICATIONS (2019)
18F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
Zuzana Nedelska et al.
MOVEMENT DISORDERS (2019)
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease
Jennifer L. Whitwell et al.
ALZHEIMERS & DEMENTIA (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
Melanie Dani et al.
BRAIN (2018)
Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
Ruiqing Ni et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease
Julian Dronse et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects
Ing-Tsung Hsiao et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies
Marta Marquie et al.
ANNALS OF NEUROLOGY (2017)
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2017)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
Konstantinos Chiotis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F}-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Abbas M. Walji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Human Radiation Dosimetry of [18F]AV-1451(T807) to Detect Tau Pathology
Jae Yong Choi et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Imaging biomarkers in tauopathies
Melanie Dani et al.
PARKINSONISM & RELATED DISORDERS (2016)
Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease
Gerard N. Bischof et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2015)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
Yasuyuki Kimura et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Tau, Amyloid, and Hypometabolism in a Patient with Posterior Cortical Atrophy
Rik Ossenkoppele et al.
ANNALS OF NEUROLOGY (2015)
A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
Zeshan Ahmed et al.
ACTA NEUROPATHOLOGICA (2014)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
Hiroki Hashimoto et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease
Tara L. Spires-Jones et al.
NEURON (2014)
Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies
Paolo Zanotti-Fregonara et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Michelle T. Fodero-Tavoletti et al.
BRAIN (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
分享论文
